Vice President and Practice Leader of the global Life Sciences Practice, Gregory K. Bell has been ranked by The Consulting Report in The Top 50 Leaders in Healthcare Consulting of 2022.
Dr. Bell’s business consulting work focuses on the economics of competitive strategy. He works with clients to build sustainable competitive advantages for products, franchises, and brands. These projects have focused on opportunity assessment, product launch, pricing and positioning, marketing strategy, channel management, and resource optimization issues. Dr. Bell has led and consulted projects concerning licensing and valuation, game theory and competitive strategy, capital budgeting and real options, and cost-benefit analyses.
Immuno-oncology, rare disease therapeutics, cell and gene therapies, and the relationship among pharmaceuticals, diagnostics, and medtech are among his areas of focus.
